717 related articles for article (PubMed ID: 7539758)
1. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
2. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.
Matsumoto Y; Tsuchida M; Hanawa H; Abo T
Immunology; 1994 Jan; 81(1):1-7. PubMed ID: 7510661
[TBL] [Abstract][Full Text] [Related]
3. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
Jung S; Donhauser T; Toyka KV; Hartung HP
J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
Körner H; Lemckert FA; Chaudhri G; Etteldorf S; Sedgwick JD
Eur J Immunol; 1997 Aug; 27(8):1973-81. PubMed ID: 9295034
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
[TBL] [Abstract][Full Text] [Related]
6. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
Vandenbark AA; Gill T; Offner H
J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of encephalitogenic T cells confers resistance to an inhibitory anti-CD4 monoclonal antibody.
Mannie MD; Morrison-Plummer J; McConnell TJ
J Immunol; 1993 Dec; 151(12):7293-306. PubMed ID: 7505025
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
Hilliard BA; Kamoun M; Ventura E; Rostami A
Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
[TBL] [Abstract][Full Text] [Related]
9. Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin-1.
Bourdoulous S; Béraud E; Le Page C; Zamora A; Ferry A; Bernard D; Strosberg AD; Couraud PO
Eur J Immunol; 1995 May; 25(5):1176-83. PubMed ID: 7539749
[TBL] [Abstract][Full Text] [Related]
10. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H
J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572
[TBL] [Abstract][Full Text] [Related]
11. Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis.
Javed NH; Gienapp IE; Cox KL; Whitacre CC
J Immunol; 1995 Aug; 155(3):1599-605. PubMed ID: 7543526
[TBL] [Abstract][Full Text] [Related]
12. A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis.
Ellerman KE; Powers JM; Brostoff SW
Nature; 1988 Jan; 331(6153):265-7. PubMed ID: 2447505
[TBL] [Abstract][Full Text] [Related]
13. Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.
Matsumoto Y; Kawai K; Tomita Y; Fujiwara M
Immunology; 1990 Feb; 69(2):215-21. PubMed ID: 1689693
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.
Archelos JJ; Jung S; Mäurer M; Schmied M; Lassmann H; Tamatani T; Miyasaka M; Toyka KV; Hartung HP
Ann Neurol; 1993 Aug; 34(2):145-54. PubMed ID: 7687838
[TBL] [Abstract][Full Text] [Related]
15. Chronic neurologic dysfunction and demyelination induced in Lewis rats by repeated injections of encephalitogenic T-lymphocyte lines.
Vandenbark AA; Nilaver G; Konat G; Teal P; Offner H
J Neurosci Res; 1986; 16(4):643-56. PubMed ID: 2432277
[TBL] [Abstract][Full Text] [Related]
16. Experimental autoimmune encephalomyelitis in the maturing central nervous system. Transfer of myelin basic protein-specific T line lymphocytes to neonatal Lewis rats.
Umehara F; Qin YF; Goto M; Wekerle H; Meyermann R
Lab Invest; 1990 Feb; 62(2):147-55. PubMed ID: 1689408
[TBL] [Abstract][Full Text] [Related]
17. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity.
Willenborg DO; Staykova MA; Miyasaka M
J Immunol; 1996 Sep; 157(5):1973-80. PubMed ID: 8757317
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D.
Matsumoto Y; Fujiwara M
Cell Immunol; 1993 Jul; 149(2):268-78. PubMed ID: 7687198
[TBL] [Abstract][Full Text] [Related]
19. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.
Goss JA; Nakafusa Y; Roland CR; Hickey WF; Flye MW
J Immunol; 1994 Nov; 153(9):3890-8. PubMed ID: 7523508
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
Gold DP; Schroder K; Powell HC; Kelly CJ
Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]